Another modifier of proteotoxicity identified from the same original yeast screen was YPK9, an ortholog of the human lysosomal P-type ATPase ATP13A2 (also known as PARK9), an enzyme known to be associated with early onset parkinsonism (Table 1). Here, ATP13A2 is linked to Parkinson disease.